期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
不同分级慢性阻塞性肺疾病患者合并骨质疏松症的相关因素分析 被引量:13
1
作者 居旭 梁永杰 汪进益 《同济大学学报(医学版)》 CAS 2018年第1期98-102,共5页
目的探讨不同分级的慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)患者发生骨量减少和骨质疏松(osteoporosis,OP)的危险因素。方法选取COPD临床稳定期患者63例(均为男性),采用双能X线骨密度测定仪测定患者左侧股骨颈... 目的探讨不同分级的慢性阻塞性肺疾病(chronic obstructive pulmonary disease,COPD)患者发生骨量减少和骨质疏松(osteoporosis,OP)的危险因素。方法选取COPD临床稳定期患者63例(均为男性),采用双能X线骨密度测定仪测定患者左侧股骨颈的骨密度值,完成慢性阻塞性肺疾病评估测试(CAT)问卷,测定肺功能并按照慢性阻塞性肺疾病全球倡议指南进行分级。测定动脉血气、BMI,并记录年龄、吸烟量。选择63位年龄相匹配,有骨密度测定资料的健康男性作为对照组。结果 COPD 2级组和对照组骨量减少和骨质疏松发生率的差异无统计学意义(P>0.05),COPD 3级、4级组骨量减少和骨质疏松的发生率均高于对照组(P<0.05)。Logistic回归分析显示:低BMI、低第1s用力呼气容积占预计值百分比(FEV1%pred)和高CAT是COPD患者发生骨质疏松的危险因素(OR值分别为0.656、0.885、1.209,P均<0.01)。结论 COPD患者骨密度的降低与气流受限,低BMI、生活质量差有关。COPD 3级、4级患者是发生骨量减少及骨质疏松症的高危人群。 展开更多
关键词 慢性阻塞性肺疾病 骨质疏松症 慢性阻塞性肺疾病评估测试 相关性 危险因素
下载PDF
The microRNAs expression changes rapidly in mice lung tissue during lipopolysaccharide-induced acute lung injury 被引量:9
2
作者 GUO Zhong-liang REN Tao +4 位作者 XU Lin ZHANG Lu YIN Qin WANG Jun-chen liang yong-jie 《Chinese Medical Journal》 SCIE CAS CSCD 2013年第1期181-183,共3页
MicroRNAs (miRNAs) are a novel class of-22-nt, .non-coding, short single-stranded RNAs producedfrom endogenous genes by the sequential action of the RNase III enzymes Drosha and Dicer. Increasing evidence shows that... MicroRNAs (miRNAs) are a novel class of-22-nt, .non-coding, short single-stranded RNAs producedfrom endogenous genes by the sequential action of the RNase III enzymes Drosha and Dicer. Increasing evidence shows that miRNAs play a critical role in regulating inflammatory and innate immunity.1,2 However, whether miRNAs are involved in the altered function of innate immune cells and ultimately contribute to the development of acute lung injury (ALl) remains largely unknown. It is worth studying the expression profiles of miRNAs in mouse lungs stimulated by lipopolysaccharide (LPS), which may be very important in the regulation of inflammatory mediators during ALI. In the present study, we investigated the expression profiles of miRNAs in LPS-induced ALI in mice. 展开更多
关键词 acute lung injury MICRORNA LIPOPOLYSACCHARIDE PATHOGENESIS
原文传递
Research and clinical value of antibacterial-application software 被引量:2
3
作者 liang yong-jie ZHAI Xiao-bo +5 位作者 HE Li-xian GUO Zhong-liang REN Tao HE Zhi-gao ZHANG Lu ZHENG Yong-hua 《Chinese Medical Journal》 SCIE CAS CSCD 2008年第1期86-89,共4页
The resistance to antibacterials therapy has been increasing in recent years,^1,2 The rational use ofanti-bacterials should include: (1) choosing the right drugs according to the scope of their antibacterials funct... The resistance to antibacterials therapy has been increasing in recent years,^1,2 The rational use ofanti-bacterials should include: (1) choosing the right drugs according to the scope of their antibacterials function and making sure they are suitable for treatment of the microorganisms that have induced the infection;^3 (2) administering anti-bacterials by a rational method according to their pharmacodynamics;^4 (3) paying attention to the systemic condition of the patients according to pharmacokinetics of the drugs.^5,6 展开更多
关键词 antibacterial-application software ANTIBACTERIAL pharmacodynamic/pharmacokinetic parameters
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部